Acupuncture for chronic hepatitis B virus infection

Cochrane Database of Systematic Reviews

Volumn 2018, Issue 3, 2018, Pages

  Liu, Jian Ping ^a   Wang, Jian ^b  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; PRIORITY JOURNAL; RETRACTED ARTICLE;

EID: 85044059641     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD005163.pub2     Document Type: Article

References (35)

1. Als-Nielsen B, Gluud LL, Gluud C. Methodological quality and treatment effects in randomised trials: a review of six empirical studies. Program & Abstract Book. 12th Cochrane Colloquium. 2004:88.
2. Als-Nielsen B, Chen W, Gluud LL, Siersma V, Hilden J, Gluud C. Are trial size and reported methodological quality associated with treatment effects? Observational study of 523 randomised trials. Program & Abstract Book. 12th Cochrane Colloquium. 2004:102-3.
3. Chen J, Chen M, Zhao B, Wang Y. Effects of acupuncture on the immunological functions in hepatitis B virus carriers. Journal of Traditional Chinese Medicine 1999;19(4):268-72.
4. de Franchis R, Hadengue A, Lau G, Lavanchy D, Lok A, McIntyre N, et al. EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002 Geneva, Switzerland. Consensus statement (long version). Journal of Hepatology 2003;39(Suppl 1):3-25.
5. Egger M, Smith G-D, Schneider M, Minder C. Bias in meta-analysis detected by a simple graphical test. BMJ (Clinical Research Ed.) 1997;315(7109):629-34.
6. Egger M, Juni P, Bartlett C, Holenstein F, Sterne J. How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study. Health Technology Assessment 2003;7(1):1-76.
7. Gluud C, Nikolova D, Klingenberg SL, Whitfield K, Alexakis N, Als-Nielsen B, et al. Cochrane Hepato-Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)). 2008, Issue 4. Art. No.: LIVER.
8. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ (Clinical Research Ed.) 2003;327:557-60.
9. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Colloboration, 2008. Available from www.cochrane-handbook.org.
10. International conference on harmonisation expert working group. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice. 1997 CFR & ICH Guidelines. 1. Vol. 1, PA 19063-2043, USA: Barnett International/PAREXEL, 1997.
11. Jüni P, Altman D, Egger M. Assessing the quality of controlled clinical trials. BMJ (Clinical Research Ed.) 2001;323(7303):42-6.
12. Kane A, Lloyd J, Zaffran M, Simonsen L, Kane M. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates. Bulletin of the World Health Organization 1999;77(10):801-7.
13. Kjaergard LL, Villumsen J, Gluud C. Reported methodological quality and discrepancies between large and small randomized trials in meta-analyses. Annals of Internal Medicine 2001;135(11):982-9.
14. Kjaergard LL, Liu JP, Als-Nielsen B, Gluud C. Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review. JAMA 2003;289(2):217-22.
15. Kunz R, Vist G, Oxman A. Randomisation to protect against selection bias in healthcare trials. Cochrane Database of Methodology Reviews 2002, Issue 4. [DOI: 10.1002/14651858.MR000012]
16. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. Journal of Viral Hepatitis 2004;11(2):97-107.
17. Lee WM. Hepatitis B virus infection. The New England Journal of Medicine 1997;337(24):1733-45.
18. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2001;34(6):1225-41.
19. Lok AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B: 2000 - summary of a workshop. Gastroenterology 2001;120(7):1828-53.
20. Lok AS. Chronic hepatitis B. The New England Journal of Medicine 2002;346(22):1682-3.
21. Mahoney FJ. Update on diagnosis, management, and prevention of hepatitis B virus infection. Clinical Microbiology Reviews 1999;12(2):351-66.
22. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses. Lancet 1998;352(9128):609-13.
23. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. International Journal of Cancer 2001;94(2):153-6.
24. Peng WW. Hepatitis B. In: Peng WW editor(s). Infectious Diseases. 5. Beijing: People's Health Publishing House, 2000:17.
25. Schulz KF, Chalmers I, Hayes R, Altman D. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408-12.
26. Vickers A, Goyal N, Harland R, Rees R. Do certain countries produce only positive results? A systematic review of controlled trials. Controlled Clinical Trials 1998;19(2):159-66.
27. Wang XY, Peng MH, Sun FY, Du XY, Xiang PD, Wang WS. A Clinical study on acupoint-injection of Huangqi in the treatment of chronic hepatitis B carriers. Chinese Acupuncture & Moxibustion 1999;19(4):223-5.
28. Wang ZH, Yue P, Lin LY, Xu J, Yu JW, Li SL. Clinical study of acupuncture and interferon - a treatment in patients with chronic hepatitis B. Chinese Journal of Clinical Hepatology 2002;18(3):187-8.
29. World Health Organization. Childhood diseases in Africa. Fact Sheet N109 (from 1996). http://www.who.int/inf-fs/en/fact109.html (accessed 28. September 2004).
30. WHO. Hepatitis B. Fact Sheet WHO/204. Revised October 2000. http://www.who.int/mediacentre/factsheets/fs204/en/ (accessed 29. October 2008).
31. World Health Organization. Hepatitis B Vaccines (published 2003). http://www.who.int/vaccines/en/hepatitisb.shtml (accessed 28.September 2004).
32. Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman GD, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ (Clinical Research Ed.) 2008;336:601-5.
33. Wu PT. Treatment of 53 cases of chronic hepatitis B with acupoint -injection. Chinese Acupuncture & Moxibustion 2002;22(6):377-8.
34. Xia WJ, Chen HP, Gu HM, Zhao CY, Xu ZY, He BB, et al. The effect of moxibustion on the immune function of chronic hepatitis B patients. Shanghai Journal of Acupuncture and Moxibustion 1988;7(3):1-4.
35. Yu MC, Yuan JM, Govindarajan S, Ross RK. Epidemiology of hepatocellular carcinoma. The Canadian Journal of Gastroenterology 2000;14(8):703-9.